Volume | 1,511,015 |
|
|||||
News | - | ||||||
Day High | 0.1734 | Low High |
|||||
Day Low | 0.1692 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Zomedica Corp | ZOM | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.1734 | 0.1692 | 0.1734 | 0.17 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,124 | 1,511,015 | $ 0.1716908 | $ 259,427 | - | 0.15 - 0.335 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:31:05 | 2 | $ 0.1717 | USD |
Zomedica Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
274.39M | 979.95M | - | 18.93M | -17.02M | -0.02 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Zomedica News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZOM Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.17 | 0.183 | 0.167 | 0.1709581 | 2,439,055 | 0.0012 | 0.71% |
1 Month | 0.168 | 0.20 | 0.1605 | 0.1760123 | 3,622,793 | 0.0032 | 1.9% |
3 Months | 0.1851 | 0.20 | 0.1518 | 0.1710132 | 3,240,479 | -0.0139 | -7.51% |
6 Months | 0.1958 | 0.245 | 0.1518 | 0.1902616 | 3,673,043 | -0.0246 | -12.56% |
1 Year | 0.2026 | 0.335 | 0.15 | 0.2176302 | 5,133,774 | -0.0314 | -15.5% |
3 Years | 0.1337 | 2.91 | 0.1337 | 0.9114054 | 31,129,028 | 0.0375 | 28.05% |
5 Years | 1.70 | 2.91 | 0.0628 | 0.7256486 | 24,878,732 | -1.53 | -89.93% |
Zomedica Description
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment. |